The Magazine for Sleep Professionals
Sunday, July 5, 2026
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced the launch of Inhaler Tales – a national campaign aimed at raising awareness about the role inhaler misuse may play in inadequate disease control.1 Central to the campaign is an animated inhaler voiced by actress, producer, and entrepreneur Sarah […]
By Nathan Costiuc, MSN, APRN, FNP-BC There’s no denying that reliable respiratory equipment has become critical amid the COVID-19 pandemic. Yet new patient concerns have recently resulted from the June 14 Philips Respironics recall of several models of ventilators, BiPAP and CPAP machines due to a manufacturing defect. After navigating […]
The Food and Drug Administration issued decisions on new tobacco product applications, addressing the over 6 million unique products and flavor variations submitted for agency review. Missing from the FDA’s announcement was a decision on a company that has the largest e-cigarette market share – Juul. “How the FDA could […]
ResMed today launched AirSense 11, available first in the U.S., the company’s next-generation PAP (positive airway pressure) device designed to help hundreds of millions of people worldwide with sleep apnea1 start and stay on therapy to treat and manage obstructive sleep apnea. AirSense 11 includes new features like Personal Therapy […]
Philip Morris International Inc. announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction. If approved, the treatment can address the significant unmet medical need of the over 83 million people, in the U.S. alone, at intermediate […]
CPAP Supply Statement “With the announcement of the suspension of shipping of PAP devices by Philips Respironics, 3B Medical has put together guidance for companies ordering CPAP. As always, 3B Medical will always give first priority to customers that have supported the company over the long term. Starting last week and concluding […]
Women who were highly exposed to ultrafine particles in air pollution during their pregnancy were more likely to have children who developed asthma, according to a study published in the American Journal of Respiratory and Critical Care Medicine. This is the first time asthma has been linked with prenatal exposure […]
Positioned at the forefront of helping people with obstructive sleep apnea (OSA) improve their health and quality of life, AR Medical Technologies launches MaskFit AR. Powered by artificial intelligence and machine learning, MaskFit AR overcomes a 30-year problem of improper patient mask fitment for people who use CPAP or BiPAPTM to […]
The use of e-cigarettes is associated with wheezing and shortness of breath in young adults and adolescents, even in those who don’t smoke cigarettes or marijuana, according to research presented at the ATS 2021 International Conference. Alayna P. Tackett, PhD, assistant professor of preventive medicine, University of Southern California Keck […]
ZOLL® Medical Corporation announced that the peer-reviewed journal Nature and Science of Sleep has published five-year results from the remedē System Post Approval Study. The data show sustained safety and efficacy of transvenous phrenic nerve stimulation for the treatment of moderate to severe central sleep apnea (CSA). The remedē® System, the only implantable device […]
